Vaccination was first pioneered in Europe and ever since, Europe has been at the heart of the global vaccine industry, playing a key role in the research and development of vaccines.
Emerging new technologies and research, such as the use of recombinant DNA, have resulted in exciting new breakthroughs and possibilities for the use of vaccines.
There are many new vaccines currently being researched and developed within our industry, including use of viral vector vaccines, non-replicating vectored vaccines, RNA vaccines, DNA plasmid technology and immunotherapy. A number of vaccines in development target diseases that are difficult to treat, such as HIV/AIDS and other viral diseases (e.g. cytomegalovirus, dengue, ebola); cancer; Alzheimer’s disease; rheumatic disorders; bacterial diseases (e.g. Clostridium difficile, chlamydia, E. coli) or parasitic diseases (e.g. malaria, hookworm, leishmaniasis) among others. In addition, several combination vaccines offer practical advantages that can boost vaccine uptake, thereby further improving public health.